Mont-Gabriel, QC · November 4–6, 2011

Organizing Committee

Dr. Paul Lasko

Dr. Étienne Richer

Dr. Gregor Andelfinger

Dr. Frédéric Charron

Dr. Charron completed his B.Sc. in Biochemistry at the University of Montreal followed by a Ph.D. in Experimental Medicine at McGill University under the supervision of Dr. Mona Nemer. He then moved to Stanford University under the supervision of Dr. Marc Tessier-Lavigne where he studied neural development and axon guidance. He started his lab in 2005 at the Institut de Recherches Cliniques de Montreal (IRCM), where he is now Associate Research Professor. He is also affiliated with the Department of Medicine, University of Montreal, and the Department of Experimental Medicine, Department of Anatomy and Cell Biology, and Department of Biology, McGill University. He has been a recipient of the Peter Lougheed Medical Research Foundation Award and a New Investigator of the Canadian Institutes of Health Research (CIHR). He is now Chercheur-Boursier of the Fonds de recherche en santé du Québec (FRSQ). His lab works on diverse aspects of neural development and axon guidance.

The work performed by Dr. Charron and his team is funded by the CIHR, the Canadian Foundation for Innovation (CFI), the Canadian Cancer Society (CCS), the Cancer Research Society (CRS), the Fonds de recherche en santé du Québec (FRSQ) and the Peter Lougheed Medical Research Foundation.

Dr. Anne-Claude Gingras

Anne-Claude Gingras is a Senior Investigator at the Samuel Lunenfeld Research Institute (Mount Sinai Hospital) and an Associate Professor in the Molecular Genetics Department at the University of Toronto. She holds a Canada Research Chair in Functional Proteomics and the Lea Reichmann Chair in Cancer Proteomics. She obtained her PhD in 2001 from McGill University for her studies on the regulation of protein synthesis which she performed under the guidance of Prof. Nahum Sonenberg. She then went on to the Institute for Systems Biology to pursue postdoctoral training under the supervision of Prof. Ruedi Aebersold, an internationally recognized leader in mass spectrometry and proteomics. Dr. Gingras was recruited to the Lunenfeld in 2005 for her expertise in proteomics and cellular signalling, and was cross-appointed in 2006 in the Department of Molecular Genetics at the University of Toronto. Since joining the Lunenfeld, Dr. Gingras has successfully established a research program aimed at understanding how serine/threonine phosphatases interact with regulatory molecules and substrates, and how they are regulated. Her studies have led to the discovery of a several signalling complexes important in health and disease, including in stroke and in the resistance to anticancer agents. Dr. Gingras has further blossomed into a technological innovator, and she has developed novel methods for analyzing how proteins inside the cell associate with each other to perform their function. Dr. Gingras’ vision is that by freely disseminating the tools created by her laboratory to other research groups and training young researchers, she will enable transformative research to be performed across the world, maximizing the impact of her own research on human health. Her productivity is evidenced by the fact that she has so far published more than 80 papers which have been cited more than 9500 times.

Dr. Geoffrey Hicks

Dr. Geoffrey G Hicks is Director of the Regenerative Medicine Program and an Associate Professor of Biochemistry & Medical Genetics in the Faculty of Medicine at the University of Manitoba. His research labs are located at CancerCare Manitoba, where he is a Senior Investigator of the Manitoba Institute of Cell Biology, and Director of the Mammalian Functional Genomics Centre. He obtained his PhD in 1991 from the University of Manitoba for his studies on the p53 tumor suppressor gene in the lab of Dr. Michael Mowat. Pursuing his interest in cancer biology, Dr Hicks held National Cancer Institute of Canada postdoctoral fellowships at Massachusetts Institute of Technology and Vanderbilt University School of Medicine. With Dr. H. Earl Ruley he developed a novel gene trapping technology as a genetic strategy to identify recessive genes in mammalian cells. Dr Hicks was recruited back the University of Manitoba and as a Canada Research Chair in Functional Genomics he developed several high throughput platforms for gene trapping and gene targeting in embryonic stem cells; including the recent International Knock-out Mouse Consortium initiative to create a public embryonic stem cell resource of knock-out mutations for all coding genes in the mouse genome. Dr. Hicks’ research program focuses on the related RNA binding proteins, TLS and EWS, to identify the transforming potential of these genes in acute myelogenous leukemia and Ewing sarcoma, respectively. His research team is currently examining the functional role of these proteins on cancer- and stem cell-associated microRNAs. His Mammalian Functional Genomics Centre is focusing their expertise in genetic engineering and transgenic technologies towards developing mouse models of human disease for the discovery of gene function in vivo and as physiologically relevant models for pre-clinical trials.

Dr. Philip Sherman

Philip M. Sherman, MD, FRCPC, is Professor of Paediatrics, Microbiology, & Dentistry at the Hospital for Sick Children, University of Toronto where he has been on faculty since 1984. Phil completed medical school at the University of Calgary in 1977 and training in pediatrics at the University of California, San Francisco (1977-1980).

Training in gastroenterology and research was completed at the Hospital for Sick Children in Toronto, and the Walter Reed Army Institute of Research in Washington, DC (1980-1984).
Phil is a Past-President of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition and a Past-President of the Canadian Association of Gastroenterology. He is the recipient of a Canada Research Chair (tier 1) in Gastrointestinal Disease (2001-2015). His research program is funded by support currently provided by the Crohn's and Colitis Foundation of Canada and the Canadian Institutes of Health Research (CIHR). His research interests focus on epithelial cell signal transduction responses to pathogenic, commensal, and probiotic bacteria.
In October 2010, Phil was awarded the prestigious 2010 Shwachman Award from the North American Society for Pediatric Gastroenterology and Nutrition (NASPGHAN). The award recognizes significant and lifelong scientific or educational contributions to the field of paediatric gastroenterology, and awardees must also hold a record of advocacy for child digestive diseases and demonstrate exemplary service to the field.
Phil assumed the position of Scientific Director of the Canadian Institutes of Health Research (CIHR) Institute of Nutrition, Metabolism and Diabetes in January, 2009.

Dr. Corey Nislow

Mr. Paul Belanger